We are live on ! Find out more
Capital Research Global Investors

Capital Research Global Investors Portfolio holdings

AUM $717B
1-Year Est. Return 35.42%
 

Capital Research Global Investors (CRGI), a division of Capital Group established in 1931 and headquartered in Los Angeles, California, is a powerhouse in active investment management, overseeing hundreds of billions in assets with a focus on global equity portfolios. Known for its long-term, research-intensive approach, CRGI employs a unique multiple-portfolio-manager system to diversify risk and enhance returns, serving institutional clients, financial advisors, and individual investors through vehicles like the American Funds mutual fund family. The firm’s investment philosophy emphasizes fundamental analysis and a deep understanding of companies worldwide, aiming to identify growth opportunities over extended horizons. As part of Capital Group’s broader mission, CRGI has built a reputation for delivering consistent, value-driven results in the global investment landscape.

This Fund
S&P 500
This Quarter Est. Return
-3.88%
1 Year Est. Return
+35.42%
3 Year Est. Return
+133.7%
5 Year Est. Return
+183.13%
10 Year Est. Return
+734.77%
AUM
$405B
AUM Growth
-$47.6B
Cap. Flow
-$11.9B
Cap. Flow %
-2.95%
Top 10 Hldgs %
28.13%
Holding
468
New
28
Increased
180
Reduced
190
Closed
28

Top Buys

Rank Stock Value
1
GE icon
GE Aerospace
GE
+$2.22B
2
SCHW
Charles Schwab
SCHW
+$2.02B
3
AMZN icon
Amazon
AMZN
+$1.98B
4
EPAM icon
EPAM Systems
EPAM
+$1.88B
5
AAPL icon
Apple
AAPL
+$1.57B

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$3.27B
2
NFLX icon
Netflix
NFLX
+$2.99B
3
MSFT icon
Microsoft
MSFT
+$1.94B
4
HD icon
Home Depot
HD
+$1.69B
5
CSX icon
CSX Corp
CSX
+$1.11B

Sector Composition

Rank Sector Weight
1 Technology 21.08%
2 Healthcare 14.23%
3 Consumer Discretionary 12.89%
4 Financials 10.35%
5 Industrials 10.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RARE icon
451
Ultragenyx Pharmaceutical
RARE
$2.65B
-425,160
Closed -$35.8M
SNCY
452
DELISTED
Sun Country Airlines
SNCY
-1,942,700
Closed -$52.9M
STZ icon
453
Constellation Brands
STZ
$22.9B
-5,949
Closed -$1.48M
VEA icon
454
Vanguard FTSE Developed Markets ETF
VEA
$238B
-12,937
Closed -$661K
VNT icon
455
Vontier
VNT
$4.52B
-7,812,341
Closed -$240M
NBIS
456
Nebius Group N.V.
NBIS
$70.5B
$0 ﹤0.01%
17,025,521
-1,038,999
-6% -$49.3M
NVRO
457
DELISTED
NEVRO CORP.
NVRO
-1,582,704
Closed -$128M
XM
458
DELISTED
Qualtrics International Inc. Class A Common Stock
XM
-2,177,797
Closed -$77.1M
IAA
459
DELISTED
IAA, Inc. Common Stock
IAA
-534,821
Closed -$27.1M
DHR.PRA
460
DELISTED
Danaher Corporation 4.75% Mandatory Convertible Preferred Stock, Series A
DHR.PRA
-62,113
Closed -$136M
AEPPL
461
DELISTED
American Electric Power Company, Inc. Corporate Unit
AEPPL
-438,505
Closed -$22M
RDS.A
462
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
-4,023,684
Closed -$175M
RDS.B
463
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
-820,787
Closed -$35.6M
NFH
464
DELISTED
New Frontier Health Corporation Ordinary Shares
NFH
-6,233,657
Closed -$71.4M
GRUB
465
DELISTED
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
-76,682
Closed -$830K
NEE.PRO
466
DELISTED
NextEra Energy, Inc. 4.872% Corporate Units
NEE.PRO
-2,080,680
Closed -$142M

Similar funds

Capital Research Global Investors's Q1 2022 Portfolio in Review

As of Q1 2022, Capital Research Global Investors held 468 positions worth $405B, down 11% from $453B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Capital Research Global Investors's Q1 2022 filing shows 28 new, 180 increased, 190 reduced and 28 closed positions. Its largest new stake was Halliburton: 17,891,897 shares worth $678M. The largest sale was Gilead Sciences, an estimated $3.27B.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Capital Research Global Investors's largest Q1 2022 buy was Halliburton: 17,891,897 shares worth $678M.
  • Capital Research Global Investors added most to GE Aerospace in Q1 2022, an estimated $2.22B increase.
  • Capital Research Global Investors's biggest Q1 2022 reduction was Gilead Sciences, cutting an estimated $3.27B.
  • Capital Research Global Investors fully exited PayPal in Q1 2022, selling an estimated $769M.
  • Capital Research Global Investors's ten largest holdings make up 28% of its $405B portfolio in Q1 2022.
  • Capital Research Global Investors opened 28 new positions and closed 28 in Q1 2022.
  • Capital Research Global Investors's portfolio value fell 11% quarter-over-quarter to $405B.

Based on Capital Research Global Investors's 13F filing for Q1 2022, filed 16 May 2022.